Get the Stockscreener App
33.17
2.28%
0.74
After Hours:
33.17
Omnicell Inc stock is traded at $33.17, with a volume of 547.19K.
It is up +2.28% in the last 24 hours and down -6.77% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
See More
Previous Close:
$32.43
Open:
$32.86
24h Volume:
547.19K
Relative Volume:
0.72
Market Cap:
$1.51B
Revenue:
$1.23B
Net Income/Loss:
$20.43M
P/E Ratio:
75.20
EPS:
0.4411
Net Cash Flow:
$95.39M
1W Performance:
+1.65%
1M Performance:
-6.77%
6M Performance:
+0.24%
1Y Performance:
+4.90%
1-Day Range:
$32.72
$33.47
1-Week Range:
$31.98
$33.47
52-Week Range:
$29.06
$55.00
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, TEM, BTSG, TXG, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
33.17 | 1.50B | 1.23B | 20.43M | 95.39M | 0.4411 |
VEEV
Veeva Systems Inc
|
260.91 | 42.48B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
77.19 | 10.71B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
56.55 | 11.62B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
80.70 | 8.94B | 638.78M | -22.66M | 122.18M | -0.1744 |
HNGE
Hinge Health Inc
|
94.15 | 7.15B | 646.34M | -512.40M | 202.76M | -6.6871 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-26 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-08-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| May-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
Precision Trading with Omnicell Inc. (OMCL) Risk Zones - Stock Traders Daily
Is Omnicell Inc (OMCL) a Bargain After 4.1% Drop? GF Value Says Undervalued - GuruFocus
Omnicell at Wells Fargo healthcare conference: betting on refresh cycle By Investing.com - Investing.com Canada
Omnicell at Wells Fargo healthcare conference: betting on refresh cycle - Investing.com
Does Embedding TraceLink’s DSCSA Tools Into Omnicell Workflows Reframe Its Cloud and Recurring Revenue Story (OMCL)? - simplywall.st
Tracelink, Inc. and Omnicell, Inc. Integrate Dscsa Compliance Solution into Hospital Pharmacy Operations - marketscreener.com
TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations - The Malaysian Reserve
Craig-Hallum Maintains Omnicell(OMCL.US) With Buy Rating - Moomoo
A new integration lets hospitals check medicines as they arrive - Stock Titan
Omnicell Inc (OMCL) Stock Up 6.3% and Still Undervalued -- GF Sc - GuruFocus
Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference - finance.yahoo.com
Omnicell Inc. ($0.001 par value) (OMCL) Peer Comparison – Compare with Others - valueresearchonline.com
Omnicell Stock Price Forecast. Should You Buy OMCL? - StockInvest.us
Omnicell Inc. ($0.001 par value) (OMCL) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Omnicell: Offers Good Value, But Uncertainty Remains (NASDAQ:OMCL) - Seeking Alpha
KeyBanc reiterates Omnicell stock rating on large pipeline growth By Investing.com - Investing.com Canada
KeyBanc reiterates Omnicell stock rating on large pipeline growth - Investing.com
Trillium Asset Management LLC Buys New Position in Omnicell, Inc. $OMCL - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Omnicell President Sells 6,753 Shares - The Motley Fool
Omnicell Market Sentiment - Benzinga España
Bank of America Corp DE Has $19.39 Million Position in Omnicell, Inc. $OMCL - MarketBeat
Omnicell (OMCL) Quarterly Figures: The Bottom-Line Figure Beats Its Comparison; Stock Move: The Share Price Adds 1.28% in the Current UpdateFinancial Data - vinanet.vn
Zacks Research Has Bearish Estimate for Omnicell Q3 Earnings - MarketBeat
Rice Hall James & Associates LLC Invests $2.15 Million in Omnicell, Inc. $OMCL - MarketBeat
Omnicell VP and Chief Accounting Officer Submits Form 4 Detailing RSU Tax Withholding and ESPP Acquisition - Kalkine Media
Omnicell (OMCL) legal chief has 4,025 shares withheld for taxes - Stock Titan
Omnicell (NASDAQ: OMCL) exec holds 22,265.8924 shares after tax move - Stock Titan
Omnicell (NASDAQ: OMCL) CEO withholds stock to cover RSU taxes - Stock Titan
Research Analysts Set Expectations for Omnicell Q1 Earnings - MarketBeat
Omnicell (NASDAQ: OMCL) insider plans sale of 3,083 shares - Stock Titan
Omnicell, Inc. $OMCL Shares Acquired by Empowered Funds LLC - MarketBeat
Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins - TradingView
Q2 2026 Omnicell Inc Earnings Call Transcript - GuruFocus
Omnicell, Inc. (OMCL) Stock Forecasts - finance.yahoo.com
OMCL Falls 20.1% in a Month as Booking and Margin Risks Build - TradingView
Quantinno Capital Management LP Has $1.92 Million Position in Omnicell, Inc. $OMCL - MarketBeat
(OMCL) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Omnicell, Inc. (OMCL) Stock Analysis: Strong Analyst Consensus with Over 55% Upside Potential - DirectorsTalk Interviews
Millennium reports 3.8% Omnicell (OMCL) stake in amended 13G filing - Stock Titan
Does Omnicell’s Profit Rebound And Higher 2026 Outlook Change The Bull Case For OMCL? - simplywall.st
First Trust Advisors LP Has $2.85 Million Stake in Omnicell, Inc. $OMCL - marketbeat.com
Royal Bank of Canada Sells 78,803 Shares of Omnicell, Inc. $OMCL - MarketBeat
Omnicell Inc (OMCL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OMNICELL, INC. 2026: Revenue $312.21M, EPS $0.52— 10-Q Summary - TradingView
Omnicell, Inc. (NASDAQ: OMCL) returns to profit with Q2 2026 growth - Stock Titan
Tranche Update on Omnicell, Inc.'s Equity Buyback Plan announced on May 22, 2025. - marketscreener.com
Omnicell, Inc. (OMCL) - DirectorsTalk Interviews
Here's Why Omnicell (OMCL) is a Strong Value Stock - Eastern Progress
Omnicell (OMCL) Is Down 12.5% After Raising 2026 Revenue Outlook And Returning To Profitability - Yahoo! Finance Canada
Weekly Recap: Omnicell, Inc. Q3/2026 revenue and analyst price target - TradingView
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):